Sunshine Biopharma Inc. (SBFM) stock
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3099% below fair value
$2.84+0.09 (+3.27%)
Close on Nov 12, 2026Market cap $790.42KP/E –Yield –
Sunshine Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Sunshine Biopharma's enterprise value was -$7.18M on Nov 11, 2026, against $1.31B a year earlier. Over the last 5 years it ranged from -$16.38M to $2.47B, with a median of $12.55M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$7.18M | -100.6% |
| 2025 | Dec 31, 2025 | $1.11B | -6.4% |
| 2024 | Dec 31, 2024 | $1.19B | – |
| 2023 | Dec 29, 2023 | -$4.98M | – |
| 2022 | Dec 30, 2022 | -$16.38M | -1557.9% |
| 2021 | Dec 31, 2021 | $1.12M | – |
| 2020 | Dec 31, 2020 | -$70.27K | – |
| 2019 | Aug 27, 2019 | -$37.27K | – |
| 2018 | Jul 10, 2018 | -$104.53K | – |
| 2017 | Dec 29, 2017 | -$187.86K | – |
| 2016 | Nov 10, 2016 | -$73.85K | – |
| 2015 | Dec 31, 2015 | -$125.19K | – |
| 2014 | Dec 31, 2014 | -$173.80K | – |
| 2013 | Dec 31, 2013 | -$70.78K | – |
| 2012 | Dec 31, 2012 | -$255.02K | – |
| 2011 | Dec 30, 2011 | -$178.30K | – |
See a number that looks wrong?